This contract involves the supply of buprenorphine medication for the needs of therapeutic units and structures of the National Organization for the Prevention and Treatment of Addictions (EOPAE). The total value of the contract is €3,490,000. Suppliers are invited to provide this essential medicati
Tender closed on 2 Feb 2026. Awaiting award.
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.